Wave Life Sciences (WVE) News Today $13.67 -1.33 (-8.87%) (As of 11/15/2024 ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period What is B. Riley's Forecast for WVE Q1 Earnings?November 16 at 4:41 AM | americanbankingnews.comTruist Financial Forecasts Strong Price Appreciation for Wave Life Sciences (NASDAQ:WVE) StockNovember 16 at 2:41 AM | americanbankingnews.comLeerink Partnrs Has Bullish Forecast for WVE FY2024 EarningsNovember 16 at 1:17 AM | americanbankingnews.comWave Life Sciences Ltd. (NASDAQ:WVE) CEO Sells $733,670.88 in StockWave Life Sciences Ltd. (NASDAQ:WVE - Get Free Report) CEO Paul Bolno sold 51,234 shares of Wave Life Sciences stock in a transaction dated Friday, November 15th. The stock was sold at an average price of $14.32, for a total value of $733,670.88. Following the sale, the chief executive officer now directly owns 217,351 shares of the company's stock, valued at approximately $3,112,466.32. This trade represents a 19.08 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink.November 15 at 10:02 PM | marketbeat.comWave Life Sciences Ltd. (NASDAQ:WVE) Released Earnings Last Week And Analysts Lifted Their Price Target To US$22.20November 15 at 8:13 PM | finance.yahoo.comFY2028 EPS Forecast for Wave Life Sciences Lifted by AnalystWave Life Sciences Ltd. (NASDAQ:WVE - Free Report) - Research analysts at HC Wainwright boosted their FY2028 earnings per share (EPS) estimates for shares of Wave Life Sciences in a note issued to investors on Wednesday, November 13th. HC Wainwright analyst A. Fein now anticipates that the companNovember 15 at 9:07 AM | marketbeat.comWave Life Sciences to Present at Jefferies London Healthcare ConferenceNovember 15 at 8:30 AM | globenewswire.comWhat is B. Riley's Estimate for WVE Q1 Earnings?Wave Life Sciences Ltd. (NASDAQ:WVE - Free Report) - Stock analysts at B. Riley issued their Q1 2025 earnings per share (EPS) estimates for shares of Wave Life Sciences in a research note issued on Wednesday, November 13th. B. Riley analyst M. El-Saadi anticipates that the company will post earniNovember 15 at 7:52 AM | marketbeat.comEquities Analysts Offer Predictions for WVE FY2024 EarningsWave Life Sciences Ltd. (NASDAQ:WVE - Free Report) - Equities researchers at Leerink Partnrs boosted their FY2024 EPS estimates for shares of Wave Life Sciences in a research report issued to clients and investors on Tuesday, November 12th. Leerink Partnrs analyst J. Schwartz now anticipates thatNovember 15 at 6:04 AM | marketbeat.comWave Life Sciences (NASDAQ:WVE) Lowered to Sell Rating by StockNews.comNovember 15 at 1:17 AM | americanbankingnews.comPositive Outlook for Wave Life Sciences Amid Strategic Advances and Regulatory MilestonesNovember 15 at 12:00 AM | markets.businessinsider.comPositive Outlook for Wave Life Sciences: FDA Support and Strategic Positioning Drive Buy RatingNovember 15 at 12:00 AM | markets.businessinsider.comInsider Selling: Wave Life Sciences Ltd. (NASDAQ:WVE) Insider Sells 36,000 Shares of StockNovember 14 at 8:18 AM | insidertrades.comWave Life Sciences Ltd. (NASDAQ:WVE) Short Interest Up 39.5% in OctoberWave Life Sciences Ltd. (NASDAQ:WVE - Get Free Report) was the target of a significant increase in short interest in October. As of October 31st, there was short interest totalling 6,820,000 shares, an increase of 39.5% from the October 15th total of 4,890,000 shares. Based on an average daily trading volume, of 1,690,000 shares, the days-to-cover ratio is currently 4.0 days.November 14 at 5:06 AM | marketbeat.comWave Life Sciences: Promising Advancements and Strategic Growth Potential Drive Buy RatingNovember 13, 2024 | markets.businessinsider.comWave Life Sciences Gains Buy Rating from Andrew Fein Amid Promising Trial Advancements and Potential Accelerated Approval PathwaysNovember 13, 2024 | markets.businessinsider.comWave Life Sciences Ltd. (NASDAQ:WVE) Q3 2024 Earnings Call TranscriptNovember 13, 2024 | msn.comWave Life Sciences' (WVE) Buy Rating Reiterated at HC WainwrightHC Wainwright reissued a "buy" rating and issued a $22.00 price target on shares of Wave Life Sciences in a report on Wednesday.November 13, 2024 | marketbeat.comWAVE Life Sciences Ltd (WVE) Q3 2024: Everything You Need to Know Ahead of EarningsNovember 12, 2024 | finance.yahoo.com48,834 Shares in Wave Life Sciences Ltd. (NASDAQ:WVE) Acquired by Privium Fund Management B.V.Privium Fund Management B.V. bought a new stake in shares of Wave Life Sciences Ltd. (NASDAQ:WVE - Free Report) in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund bought 48,834 shares of the company's stock, valued at approximatelNovember 10, 2024 | marketbeat.comWave Life Sciences treatment of Huntington’s disease gets FDA orphan designationNovember 9, 2024 | markets.businessinsider.comWave Life Sciences (NASDAQ:WVE) Reaches New 12-Month High - Still a Buy?Wave Life Sciences (NASDAQ:WVE) Reaches New 1-Year High - Still a Buy?November 8, 2024 | marketbeat.comB. Riley Issues Positive Forecast for Wave Life Sciences (NASDAQ:WVE) Stock PriceNovember 7, 2024 | americanbankingnews.comWave Life Sciences (WVE) to Release Earnings on TuesdayWave Life Sciences (NASDAQ:WVE) will be releasing earnings before the market opens on Tuesday, November 12, Zacks reports.November 5, 2024 | marketbeat.comWave Life Sciences price target raised to $22 from $19 at B. RileyNovember 4, 2024 | markets.businessinsider.comB. Riley Increases Wave Life Sciences (NASDAQ:WVE) Price Target to $22.00B. Riley raised their price target on shares of Wave Life Sciences from $19.00 to $22.00 and gave the stock a "buy" rating in a research note on Monday.November 4, 2024 | marketbeat.comEmerald Advisers LLC Acquires 388,280 Shares of Wave Life Sciences Ltd. (NASDAQ:WVE)Emerald Advisers LLC grew its holdings in shares of Wave Life Sciences Ltd. (NASDAQ:WVE - Free Report) by 15.6% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 2,881,510 shares of the company's stock after buying aNovember 3, 2024 | marketbeat.comWave Life Sciences: Strategic Advancements and Promising Pipeline Drive Buy RatingNovember 1, 2024 | markets.businessinsider.comBRIEF-Wave Life Sciences Plans To Have Five Galnac-RNA Editing Or GalNAc-siRNA Programs In Clinic By 2026November 1, 2024 | sg.finance.yahoo.comHC Wainwright Reaffirms "Buy" Rating for Wave Life Sciences (NASDAQ:WVE)HC Wainwright reaffirmed a "buy" rating and set a $22.00 price objective on shares of Wave Life Sciences in a report on Thursday.October 31, 2024 | marketbeat.comWave Life Sciences Highlights Growing Pipeline at Research Day, including INHBE siRNA Program for Obesity and New RNA Editing ProgramsOctober 30, 2024 | globenewswire.comHow to play biotech stocks: Insmed and Wave Life SciencesOctober 29, 2024 | finance.yahoo.comOptimistic Outlook on Wave Life Sciences: Strategic Initiatives and Advancements Highlighted by Joseph SchwartzOctober 29, 2024 | markets.businessinsider.comWave Life Sciences Ltd. (NASDAQ:WVE) Receives Consensus Rating of "Buy" from AnalystsWave Life Sciences Ltd. (NASDAQ:WVE - Get Free Report) has earned a consensus rating of "Buy" from the ten ratings firms that are covering the firm, Marketbeat Ratings reports. One research analyst has rated the stock with a hold rating, eight have given a buy rating and one has issued a strongOctober 29, 2024 | marketbeat.comMoody Aldrich Partners LLC Purchases 123,703 Shares of Wave Life Sciences Ltd. (NASDAQ:WVE)Moody Aldrich Partners LLC raised its position in Wave Life Sciences Ltd. (NASDAQ:WVE - Free Report) by 69.0% in the 3rd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 303,062 shares of the company's stock after purchasing an additional 123,703October 24, 2024 | marketbeat.com1 Brand-New Big Reason to Buy This Biotech Stock Right NowOctober 24, 2024 | fool.comRBC Capital Remains a Hold on Wave Life Sciences (WVE)October 21, 2024 | markets.businessinsider.comKorro Bio Is Lagging Wave Life Sciences In RNA Editing. Why It Could Ultimately Lead The Space.October 21, 2024 | investors.comPaul Bolno Sells 90,474 Shares of Wave Life Sciences Ltd. (NASDAQ:WVE) StockOctober 20, 2024 | insidertrades.comSG Americas Securities LLC Has $300,000 Holdings in Wave Life Sciences Ltd. (NASDAQ:WVE)SG Americas Securities LLC lessened its holdings in Wave Life Sciences Ltd. (NASDAQ:WVE - Free Report) by 72.7% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 36,563 shares of the company's stock after selling 97,264 shares duOctober 20, 2024 | marketbeat.comWave Life Sciences Ltd. (NASDAQ:WVE) CEO Paul Bolno Sells 90,474 SharesWave Life Sciences Ltd. (NASDAQ:WVE - Get Free Report) CEO Paul Bolno sold 90,474 shares of Wave Life Sciences stock in a transaction dated Wednesday, October 16th. The shares were sold at an average price of $15.00, for a total value of $1,357,110.00. Following the sale, the chief executive officer now owns 268,585 shares of the company's stock, valued at approximately $4,028,775. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.October 18, 2024 | marketbeat.comLeerink Partnrs Analysts Raise Earnings Estimates for WVEWave Life Sciences Ltd. (NASDAQ:WVE - Free Report) - Analysts at Leerink Partnrs upped their Q3 2024 earnings per share (EPS) estimates for Wave Life Sciences in a research note issued to investors on Wednesday, October 16th. Leerink Partnrs analyst J. Schwartz now expects that the company will pOctober 18, 2024 | marketbeat.comWave Life Sciences Rockets 70% on Historic RNA Editing SuccessWave Life Sciences' RNA editing advances have generated investor interest as the company strives to become a leading force in the treatment of genetic diseases.October 18, 2024 | marketbeat.comRaymond James Upgrades Wave Life Sciences (WVE)October 18, 2024 | msn.comPositive Outlook for Wave Life Sciences Driven by Promising RNA Editing Data and Strategic OpportunitiesOctober 18, 2024 | markets.businessinsider.comWave Life Sciences: Increased Probability of Success Drives Buy Rating Amid Platform AdvancementsOctober 18, 2024 | markets.businessinsider.comWave Life Sciences (NASDAQ:WVE) Shares Gap Down - Here's What HappenedWave Life Sciences (NASDAQ:WVE) Shares Gap Down - What's Next?October 17, 2024 | marketbeat.comJPMorgan Chase & Co. Increases Wave Life Sciences (NASDAQ:WVE) Price Target to $17.00JPMorgan Chase & Co. raised their price target on Wave Life Sciences from $13.00 to $17.00 and gave the company an "overweight" rating in a report on Thursday.October 17, 2024 | marketbeat.comWave Life Sciences (NASDAQ:WVE) Receives Buy Rating from HC WainwrightHC Wainwright restated a "buy" rating and set a $22.00 target price on shares of Wave Life Sciences in a research report on Thursday.October 17, 2024 | marketbeat.comWave Life Sciences: Buy Rating Affirmed on Promising RNA Editing Platform DataOctober 17, 2024 | markets.businessinsider.com Get Wave Life Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for WVE and its competitors with MarketBeat's FREE daily newsletter. Email Address The Tesla Trade Is Back In Business (Ad)If you held shares of Tesla throughout 2024, you know It’s been a year of extreme highs and lows… But according to our one expert, new yearly highs are on the horizon… In his words, Tesla is building momentum like in 2020, especially as Trump supports the EV maker. Which is why we’re emailing you now… You see, most people will simply buy shares of Tesla ahead of the election… But as they say “There is more than one way to skin a cat” In fact, we’ve found another way to play shares of Tesla. Discover how to trade Tesla, simply follow this link here. WVE Media Mentions By Week WVE Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. WVE News Sentiment▼0.560.56▲Average Medical News Sentiment WVE News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. WVE Articles This Week▼355▲WVE Articles Average Week Get Wave Life Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for WVE and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies AKBA News URGN News RAPT News MRNS News VKTX News LEGN News ASND News ELAN News CYTK News BPMC News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:WVE) was last updated on 11/17/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredThere is a little known company that is changing warfareWith geo - political instability around the world investors are flocking to defense contract stocks. There...Reticulate | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Wave Life Sciences Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Wave Life Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free WVE Stock Alerts